Core Viewpoint - Spring Medical has experienced a continuous decline in stock price over the past four days, with a cumulative drop of 8.63% [1] Company Overview - Beijing Spring Medical Co., Ltd. was established on February 12, 1998, and went public on December 30, 2021. The company specializes in the research, production, and sales of implantable orthopedic medical devices [1] - The main products include joint prosthetics and spinal implant products, covering major human joints such as hip, knee, shoulder, and elbow, as well as a full range of spinal fixation systems [1] - The company's revenue composition is primarily from medical device products (99.89%), with a minor contribution from other sources (0.11%) [1] Fund Holdings - Two funds under Changxin Fund have significant holdings in Spring Medical, totaling 108,900 shares. As of the latest stock price of 22.76 yuan, the funds have incurred a floating loss of 18,500 yuan today, with a total loss of 234,100 yuan over the past four days [2] - Changxin Stable Selection Mixed Fund (A009606) holds 65,753 shares, accounting for 1.76% of the fund's net value, while Changxin Easy Progress Mixed Fund (A003126) holds 43,138 shares, representing 1.57% of its net value [2] - The floating losses for the Changxin Stable Selection Mixed Fund today are approximately 11,200 yuan, with a total loss of 141,400 yuan over the four-day decline. For the Changxin Easy Progress Mixed Fund, the floating loss today is about 7,333 yuan, with a total loss of 92,700 yuan during the same period [2]
春立医疗股价连续4天下跌累计跌幅8.63%